286
Participants
Start Date
July 31, 2014
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2019
NaF PET/CT Imaging
Diagnostic imaging test that is considered investigational
99mTc-medronate whole body bone scan with SPECT
99mTc-medronate whole body bone scan with SPECT imaging. Note, that this is a standard procedure in this patient population and thus is not considered investigational.
18F-Sodium Fluoride (NaF)
A single radioactive dose of 18F-NaF (185-370 MBq) is intravenously administered to subject 60 minutes prior to PET/CT imaging to evaluate whether or not subject has bone metastasis from advanced prostate or breast cancer. Entire procedure from injection to scan completion will take about 2.25 hours
Edmonton Cross Cancer Institute, Edmonton
BC Cancer Agency, Vancouver
QEII Health Sciences Centre, Halifax
Hamilton Health Sciences Corp., Hamilton
St. Joseph's Healthcare Hamilton, Hamilton
London Health Sciences Centre, London
The Ottawa Hospital, Ottawa
University Health Network, Toronto
Centre hospitalier universitaire de Sherbrooke, Fleurimont
Centre hospitalier universitaire de Montréal, Montreal
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
British Columbia Cancer Agency
OTHER